+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pharmaceutical Licensing"

Big Pharma Licensing Trends, 2014-18 - Product Thumbnail Image

Big Pharma Licensing Trends, 2014-18

  • Report
  • August 2019
  • 82 Pages
  • Global
Deal-Making Trends in Pharma - Thematic Research - Product Thumbnail Image

Deal-Making Trends in Pharma - Thematic Research

  • Report
  • September 2019
  • 56 Pages
  • Global
From
From
  • 3 Results (Page 1 of 1)
Loading Indicator

The Pharmaceutical Licensing market is a subset of the pharmaceutical industry that involves the transfer of rights to develop, manufacture, and market a drug or biologic from one company to another. This type of agreement is often used to bring a drug to market faster, as the company receiving the license can leverage the existing research and development of the company providing the license. Pharmaceutical Licensing agreements can also be used to expand the reach of a drug, as the company receiving the license can market the drug in different countries or regions. Companies in the Pharmaceutical Licensing market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more